Pharmaids Pharma

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.20",
    "chg": -0.72,
    "chgp": "-2.41%",
    "dir": -1,
    "prev_price": "29.92",
    "mcapval": "99.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE117D01018",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "15.52 k",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3985409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PharmaidsPharma_mojoScore_3985409.png",
        "date": "2026-05-11 10:10:28",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3968067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3968067.png",
        "date": "2026-04-29 10:10:36",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3952050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3952050.png",
        "date": "2026-04-18 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3935178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3935178.png",
        "date": "2026-04-07 10:10:02",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 28.5 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs285-3924462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_priceRelatedfactors_3924462.png",
        "date": "2026-03-30 11:19:32",
        "description": "A sharp decline has pushed Pharmaids Pharmaceuticals Ltd to a fresh 52-week low of Rs 28.5 on 30 Mar 2026, marking a significant 61.2% drop from its peak of Rs 73.45 within the last year. This steep fall comes amid a broader market downturn, but the stock’s underperformance far exceeds sector and benchmark indices."
      },
      {
        "title": "Markets Rally, But Pharmaids Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2905-3919635",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_priceRelatedfactors_3919635.png",
        "date": "2026-03-27 12:47:12",
        "description": ""
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3917905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3917905.png",
        "date": "2026-03-26 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3888508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3888508.png",
        "date": "2026-03-13 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3864244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PharmaidsPharma_mojoScore_3864244.png",
        "date": "2026-03-02 10:10:21",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 117,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "08-May-2026",
      "details": "Pursuant to the Regulation 24A of SEBI (LODR) Regulations 2015 enclosed is the Annual Secretarial Compliance Report for the year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "24-Apr-2026",
      "details": "Newspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended March 31 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-05-11 10:10:28

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-29 10:10:36

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-18 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-07 10:10:02

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 28.5 as Sell-Off Deepens

2026-03-30 11:19:32

A sharp decline has pushed Pharmaids Pharmaceuticals Ltd to a fresh 52-week low of Rs 28.5 on 30 Mar 2026, marking a significant 61.2% drop from its peak of Rs 73.45 within the last year. This steep fall comes amid a broader market downturn, but the stock’s underperformance far exceeds sector and benchmark indices.

Read full news article

Markets Rally, But Pharmaids Pharmaceuticals Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-27 12:47:12

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-26 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-13 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-03-02 10:10:21

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

View All News